Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a single-arm prospective clinical trial to determine the safety and feasibility of
using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head
and neck cancer patients.